Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma.

van der Meer PF, Cancelas JA, Vassallo RR, Rugg N, Einarson M, Hess JR; BEST Collaborative.

Transfusion. 2011 Jan;51 Suppl 1:45S-49S. doi: 10.1111/j.1537-2995.2010.02962.x.

PMID:
21223295
2.

Platelet concentrates from fresh or overnight-stored blood, an international study.

Dijkstra-Tiekstra MJ, van der Meer PF, Cardigan R, Devine D, Prowse C, Sandgren P, de Wildt-Eggen J; Biomedical Excellence for Safer Transfusion Collaborative.

Transfusion. 2011 Jan;51 Suppl 1:38S-44S. doi: 10.1111/j.1537-2995.2010.02973.x.

PMID:
21223294
3.

Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.

Serrano K, Scammell K, Weiss S, Culibrk B, Levin E, Gyöngyössy-Issa M, Devine DV.

Transfusion. 2010 Feb;50(2):344-53. doi: 10.1111/j.1537-2995.2009.02441.x. Epub 2009 Oct 15.

PMID:
19843287
4.

Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.

Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, de Wildt-Eggen J.

Transfusion. 2008 Oct;48(10):2114-21. doi: 10.1111/j.1537-2995.2008.01849.x. Epub 2008 Jul 17.

PMID:
18647365
5.

Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.

Levin E, Culibrk B, Gyöngyössy-Issa MI, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV.

Transfusion. 2008 Nov;48(11):2331-7. doi: 10.1111/j.1537-2995.2008.01836.x. Epub 2008 Jun 27.

PMID:
18631169
6.

Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures.

van der Meer PF, Cancelas JA, Cardigan R, Devine DV, Gulliksson H, Sparrow RL, Vassallo RR, de Wildt-Eggen J, Baumann-Baretti B, Hess JR; BEST Collaborative.

Transfusion. 2011 Jan;51 Suppl 1:15S-24S. doi: 10.1111/j.1537-2995.2010.02959.x.

PMID:
21223291
7.

Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study.

Sandgren P, Callaert M, Shanwell A, Gulliksson H.

Transfusion. 2008 Apr;48(4):688-96. doi: 10.1111/j.1537-2995.2007.01593.x. Epub 2008 Jan 7.

PMID:
18194379
8.

Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method.

Lu FQ, Kang W, Peng Y, Wang WM.

Transfusion. 2011 Oct;51(10):2199-207. doi: 10.1111/j.1537-2995.2011.03137.x. Epub 2011 Apr 14.

PMID:
21492181
9.

Platelet concentrates prepared after a 20- to 24-hour hold of the whole blood at 22°C.

Slichter SJ, Corson J, Jones MK, Christoffel T, Pellham E, Bolgiano D.

Transfusion. 2012 Sep;52(9):2043-8. doi: 10.1111/j.1537-2995.2011.03546.x. Epub 2012 Feb 10.

10.

A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjects.

Dumont LJ, Dumont DF, Unger ZM, Siegel A, Szczepiorkowski ZM, Corson JS, Jones MK, Christoffel T, Pellham E, Bailey SL, Slichter SJ; BEST Collaborative.

Transfusion. 2011 Jun;51(6):1241-8. doi: 10.1111/j.1537-2995.2010.03007.x. Epub 2011 Jan 7.

PMID:
21214584
11.

Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.

Thibault L, Beauséjour A, de Grandmont MJ, Lemieux R, Leblanc JF.

Transfusion. 2006 Aug;46(8):1292-9.

PMID:
16934062
12.

Effect of additive solutions on red blood cell (RBC) membrane properties of stored RBCs prepared from whole blood held for 24 hours at room temperature.

Veale MF, Healey G, Sparrow RL.

Transfusion. 2011 Jan;51 Suppl 1:25S-33S. doi: 10.1111/j.1537-2995.2010.02960.x.

PMID:
21223292
13.

Facilitating blood component preparation: the impact of overnight room temperature storage.

McLaughlin LS, Moroff G, Benjamin RJ.

Transfusion. 2010 Feb;50(2):278-80. doi: 10.1111/j.1537-2995.2009.02565.x. Epub 2010 Jan 15. No abstract available.

PMID:
20088837
14.
15.

Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.

Skripchenko A, Kurtz J, Moroff G, Wagner SJ.

Transfusion. 2008 Jul;48(7):1469-77. doi: 10.1111/j.1537-2995.2008.01733.x. Epub 2008 May 13.

PMID:
18482181
16.

The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.

Wagner SJ, Vassallo R, Skripchenko A, Einarson M, Seetharaman S, Moroff G.

Transfusion. 2008 Jun;48(6):1072-80. doi: 10.1111/j.1537-2995.2008.01690.x. Epub 2008 Mar 25.

PMID:
18373503
17.

Manufacture of pooled platelets in additive solution and storage in an ELX container after an overnight warm temperature hold of platelet-rich plasma.

Alhumaidan H, Cheves T, Holme S, Sweeney JD.

Am J Clin Pathol. 2011 Oct;136(4):638-45. doi: 10.1309/AJCPFD87THDWCSVA.

18.

Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution.

Slichter SJ, Bolgiano D, Corson J, Jones MK, Christoffel T, Bailey SL, Pellham E.

Transfusion. 2014 Sep;54(9):2283-91. doi: 10.1111/trf.12634. Epub 2014 Mar 28.

19.
20.

Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.

Ringwald J, Haager B, Krex D, Zimmermann R, Strasser E, Antoon M, De Schrijver E, Eckstein R.

Transfusion. 2006 Jun;46(6):942-8.

PMID:
16734810
Items per page

Supplemental Content

Write to the Help Desk